脊椎デバイスおよび生物製剤市場2020：地域の見通し（アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ）別のサイズ、業界分析レポート、成長の可能性、価格動向、競争力のある市場シェア、市場統計と予測2020-2025 (アップデート版あり)

このレポートには、最新の市場図、統計、データが含まれています

ライセンスを選択

概要
目次

まとめグローバル脊椎デバイスおよび生物製剤市場は、2015年から2019年までのCAGR xx％でxxx百万米ドルと評価されました。その後、2020年にはXXX百万米ドルに達し、2020年から2025年までのCAGRはxx％になります。

世界の脊椎デバイスおよび生物製剤市場では、このレポートは特に北アメリカ、南アメリカ、ヨーロッパとアジア太平洋、および中東とアフリカに焦点を当てています。このレポートは、アプリケーション、タイプ、地域、および製造業者に基づいて市場を分類します。

メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Nuvasive
Orthofix International
Exactech
Wright Medical Group
Johnson & Johnson
Zimmer Biomet
Globus Medical
K2M
Medtronic
Alphatec Holdings
RTI Surgical

地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）

タイプによる市場細分化：
脊椎固定術＆固定
モーション保存
非融合技術
骨折治療
他の
アプリケーションによる市場細分化：
病院
歩行外科センター
クリニック
他の
この調査は、次の重要な質問に対する回答を提供します。
• 2020年から2025年の予測期間における脊椎デバイスおよび生物製剤市場の推定成長率と市場シェアおよび規模はどのくらいですか？
• 予測期間2020年から2025年の脊椎デバイスおよび生物製剤市場の原動力は何ですか？
• 著名なマーケットプレーヤーは誰ですか？彼らは他の競合他社に対してどのように競争力を獲得しましたか？
• 世界中の脊椎デバイスおよび生物製剤の業界の進歩に影響を与える市場動向は何ですか？
• 業界の進歩を制限する主な課題と脅威は何ですか？
• 市場は著名な市場プレーヤーにとってどのような機会を持っていますか？
このレポートに関する特別な要件がある場合は、お知らせください。カスタムレポートを提供できます。

注–より正確な市場予測を提供するために、COVID-19の影響を考慮して、すべてのレポートが配信前に更新されます。

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Spinal Devices and Biologics Market Size Growth Rate by Type (2020-2025)
1.3.2 Spinal Fusion & Fixation
1.3.3 Motion Preservation
1.3.4 Non-Fusion Technologies
1.3.5 Fracture Treatment
1.3.6 Other
1.4 Market Segment by Application
1.4.1 Global Spinal Devices and Biologics Market Share by Application (2020-2025)
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.4.4 Clinics
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Spinal Devices and Biologics Production Value 2015-2025
2.1.2 Global Spinal Devices and Biologics Production 2015-2025
2.1.3 Global Spinal Devices and Biologics Capacity 2015-2025
2.1.4 Global Spinal Devices and Biologics Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Spinal Devices and Biologics Market Size CAGR of Key Regions
2.2.2 Global Spinal Devices and Biologics Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Spinal Devices and Biologics Capacity by Manufacturers
3.1.2 Global Spinal Devices and Biologics Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Spinal Devices and Biologics Revenue by Manufacturers (2015-2019)
3.2.2 Spinal Devices and Biologics Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Spinal Devices and Biologics Market Concentration Ratio (CR5 and HHI)
3.3 Spinal Devices and Biologics Price by Manufacturers
3.4 Key Manufacturers Spinal Devices and Biologics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Spinal Devices and Biologics Market
3.6 Key Manufacturers Spinal Devices and Biologics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Spinal Fusion & Fixation Production and Production Value (2015-2019)
4.1.2 Motion Preservation Production and Production Value (2015-2019)
4.1.3 Non-Fusion Technologies Production and Production Value (2015-2019)
4.1.4 Fracture Treatment Production and Production Value (2015-2019)
4.1.5 Other Production and Production Value (2015-2019)
4.2 Global Spinal Devices and Biologics Production Market Share by Type
4.3 Global Spinal Devices and Biologics Production Value Market Share by Type
4.4 Spinal Devices and Biologics Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Spinal Devices and Biologics Consumption by Application

6 Production by Regions
6.1 Global Spinal Devices and Biologics Production (History Data) by Regions 2015-2019
6.2 Global Spinal Devices and Biologics Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Spinal Devices and Biologics Production Growth Rate 2015-2019
6.3.2 United States Spinal Devices and Biologics Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Spinal Devices and Biologics Import & Export
6.4 European Union
6.4.1 European Union Spinal Devices and Biologics Production Growth Rate 2015-2019
6.4.2 European Union Spinal Devices and Biologics Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Spinal Devices and Biologics Import & Export
6.5 China
6.5.1 China Spinal Devices and Biologics Production Growth Rate 2015-2019
6.5.2 China Spinal Devices and Biologics Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Spinal Devices and Biologics Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia

7 Spinal Devices and Biologics Consumption by Regions
7.1 Global Spinal Devices and Biologics Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Spinal Devices and Biologics Consumption by Type
7.2.2 United States Spinal Devices and Biologics Consumption by Application
7.3 European Union
7.3.1 European Union Spinal Devices and Biologics Consumption by Type
7.3.2 European Union Spinal Devices and Biologics Consumption by Application
7.4 China
7.4.1 China Spinal Devices and Biologics Consumption by Type
7.4.2 China Spinal Devices and Biologics Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Spinal Devices and Biologics Consumption by Type
7.5.2 Rest of World Spinal Devices and Biologics Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia

8 Company Profiles
8.1 Nuvasive
8.1.1 Nuvasive Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Spinal Devices and Biologics
8.1.4 Spinal Devices and Biologics Product Introduction
8.1.5 Nuvasive Recent Development
8.2 Orthofix International
8.2.1 Orthofix International Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Spinal Devices and Biologics
8.2.4 Spinal Devices and Biologics Product Introduction
8.2.5 Orthofix International Recent Development
8.3 Exactech
8.3.1 Exactech Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Spinal Devices and Biologics
8.3.4 Spinal Devices and Biologics Product Introduction
8.3.5 Exactech Recent Development
8.4 Wright Medical Group
8.4.1 Wright Medical Group Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Spinal Devices and Biologics
8.4.4 Spinal Devices and Biologics Product Introduction
8.4.5 Wright Medical Group Recent Development
8.5 Johnson & Johnson
8.5.1 Johnson & Johnson Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Spinal Devices and Biologics
8.5.4 Spinal Devices and Biologics Product Introduction
8.5.5 Johnson & Johnson Recent Development
8.6 Zimmer Biomet
8.6.1 Zimmer Biomet Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Spinal Devices and Biologics
8.6.4 Spinal Devices and Biologics Product Introduction
8.6.5 Zimmer Biomet Recent Development
8.7 Globus Medical
8.7.1 Globus Medical Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Spinal Devices and Biologics
8.7.4 Spinal Devices and Biologics Product Introduction
8.7.5 Globus Medical Recent Development
8.8 K2M
8.8.1 K2M Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Spinal Devices and Biologics
8.8.4 Spinal Devices and Biologics Product Introduction
8.8.5 K2M Recent Development
8.9 Medtronic
8.9.1 Medtronic Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Spinal Devices and Biologics
8.9.4 Spinal Devices and Biologics Product Introduction
8.9.5 Medtronic Recent Development
8.10 Alphatec Holdings
8.10.1 Alphatec Holdings Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Spinal Devices and Biologics
8.10.4 Spinal Devices and Biologics Product Introduction
8.10.5 Alphatec Holdings Recent Development
8.11 RTI Surgical

9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Spinal Devices and Biologics Capacity, Production Forecast 2020-2025
9.1.2 Global Spinal Devices and Biologics Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Spinal Devices and Biologics Production and Value Forecast by Regions 2020-2025
9.2.2 Global Spinal Devices and Biologics Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Spinal Devices and Biologics Production Forecast by Type
9.7.2 Global Spinal Devices and Biologics Production Value Forecast by Type
9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Spinal Devices and Biologics Sales Channels
10.2.2 Spinal Devices and Biologics Distributors
10.3 Spinal Devices and Biologics Customers

11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter\'s Five Forces Analysis

12 Key Findings

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer